ALT

Altimmune, Inc. is a prominent clinical-stage biopharmaceutical company headquartered in Gaithersburg, Maryland, specializing in the development of intranasal vaccines and immunomodulatory therapies to address urgent unmet medical needs. Utilizing its proprietary technology platforms, Altimmune is advancing a diverse pipeline focused on infectious diseases and liver disorders, aiming to redefine therapeutic solutions in these critical areas. With a robust commitment to research and development, the company is well-positioned to deliver transformative innovations that enhance patient care and solidify its competitive edge within the rapidly evolving biopharmaceutical sector.